Research synthesisModerate evidenceMixed effect size4 studies · 3 beneficial · 1 neutral · 0 harmful
Across 4 studies, 3 reported beneficial effects of L-carnitine supplementation on reducing blood cholesterol, with effect sizes ranging from small to large. The largest, most recent trial in women with PCOS (n=110) showed a large beneficial effect at 3000 mg/day over 42 days, while meta-analyses in type 2 diabetes and PCOS reported small-to-moderate reductions. The limited evidence shows mixed effect sizes (small to large) and is drawn primarily from clinical populations (PCOS, type 2 diabetes) with the most-supported dose at or above 2 g/day.
- Effective dose range: ≥2 g/day
- Studied populations: women with PCOS, adults with type 2 diabetes
Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive (3 of 4 studies beneficial) — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The single neutral study was a large meta-analysis in type 2 diabetes (n=2041) showing a small, non-significant reduction, suggesting effect may be smaller in that population than in PCOS. Most studies did not report form or had variable dosing, limiting dose-response conclusions.
Generated Jun 12, 2026